Quarterly report pursuant to Section 13 or 15(d)

INVENTORIES

v3.23.2
INVENTORIES
6 Months Ended
Jun. 30, 2023
INVENTORIES  
INVENTORIES

6.

Inventories

Inventories for the periods presented consist of the following (in thousands):

As of

June 30, 2023

    

December 31, 2022

Raw materials

$

6,878

$

4,555

Work in process

2,046

2,659

Finished goods

1,858

1,904

Total

$

10,782

$

9,118

Inventories as of June 30, 2023 and December 31, 2022 include inventories acquired from Forma (now Novo Nordisk) pursuant to the license and transition agreement. As of June 30, 2023 and December 31, 2022, we have $0.7 million and $0.8 million, respectively, in advance payments to the manufacturer of our raw materials, which were included within prepaid and other current assets in the condensed balance sheet.